O Boston Medical Center Health System cumpre as leis federais de direitos civis aplicáveis e não discrimina com base em idade, raça, cor, origem nacional (incluindo proficiência limitada em inglês e idioma principal), religião, cultura, deficiência física ou mental, status socioeconômico, sexo, orientação sexual e identidade e/ou expressão de gênero. O BMCHS oferece ajuda e serviços gratuitos para pessoas com deficiência e serviços linguísticos gratuitos para pessoas cujo idioma principal não é o inglês.
Para ler nossa Declaração de Não Discriminação completa, clique aqui.
Natasha S. Hochberg, MD, MPH, is an infectious disease physician at Boston Medical Center (BMC) and a volunteer associate professor of medicine in the Department of Infectious Diseases at Boston University Chobanian and Avedisian School of Medicine. Dr. Hochberg sees travelers and patients with tropical diseases in the Center for infectious Diseases, with a particular focus on Chagas disease and
... other parasitic infections. Her primary position is Director of Global Health Translational Medicine at Novartis Institutes for BioMedical Research. Previously, Dr. Hochberg was an Epidemic Intelligence Service (EIS) officer at the Centers for Disease and Prevention (CDC) in the Division of Parasitic Diseases and worked internationally on projects related to malaria, visceral leishmaniasis, guinea worm disease, and lymphatic filariasis. She has also held roles such as co-director of the travel clinic and Director of Tropical Medicine at BMC, and the co-site director for GeoSentinel, an international surveillance system of diseases in travelers and migrants. Her research focuses on tropical diseases, particularly the impact of malnutrition and parasitic disease on tuberculosis (TB), tropical diseases in immigrant populations, and preventing diseases in international travelers. She was the principal investigator of the TB LION study (Learning the Impact Of Nutrition) in Pondicherry, India which investigated the impact of malnutrition and parasite infections on the immune response to TB and how this changes after providing a high-protein food package, multivitamin, and deworming. She was also site principal investigator of the US-Indo RePORT study in Pondicherry, India. She is part of the American Society of Tropical Medicine and Hygiene where she serves as President for the Clinical Group, and previously served as a member of the Scientific Program Committee, a clinical group councilor, and as the Chair for the Subcommittee on Pneumonia, Respiratory Infections and TB.